Your browser doesn't support javascript.
loading
Periprocedural adverse events after endoscopic resection of T1 colorectal carcinomas.
van de Ven, Steffi E M; Backes, Yara; Hilbink, Mirrian; Seerden, Tom C J; Kessels, Koen; de Vos Tot Nederveen Cappel, Wouter H; Groen, John N; Wolfhagen, Frank H J; Geesing, Joost M J; Borg, Frank Ter; van Bergeijk, Jeroen; Spanier, B W M; Mundt, Marco W; Pullens, H J M; Boonstra, Jurjen J; Opsteeg, Bart; van Lent, Anja U G; Schrauwen, Ruud W M; Laclé, Miangela M; Moons, Leon M G; Terhaar Sive Droste, Jochim S.
Afiliação
  • van de Ven SEM; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Backes Y; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Hilbink M; Jeroen Bosch Academy, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Seerden TCJ; Department of Gastroenterology and Hepatology, Amphia Hospital, Breda, the Netherlands.
  • Kessels K; Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • de Vos Tot Nederveen Cappel WH; Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, the Netherlands.
  • Groen JN; Department of Gastroenterology and Hepatology, Sint Jansdal Harderwijk, Harderwijk, the Netherlands.
  • Wolfhagen FHJ; Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Geesing JMJ; Department of Gastroenterology and Hepatology, Diakonessenhuis, Utrecht, the Netherlands.
  • Borg FT; Department of Gastroenterology and Hepatology, Deventer Hospital, Deventer, the Netherlands.
  • van Bergeijk J; Department of Gastroenterology and Hepatology, Gelderse Vallei, Ede, the Netherlands.
  • Spanier BWM; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Mundt MW; Department of Gastroenterology and Hepatology, Flevo Hospital, Almere, the Netherlands.
  • Pullens HJM; Department of Gastroenterology and Hepatology, Meander Medical Center, Amersfoort, the Netherlands.
  • Boonstra JJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Opsteeg B; Department of Gastroenterology and Hepatology, Groene Hart Hospital, Gouda, the Netherlands.
  • van Lent AUG; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • Schrauwen RWM; Department of Gastroenterology and Hepatology, Bernhoven, Uden, the Netherlands.
  • Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Moons LMG; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Terhaar Sive Droste JS; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
Gastrointest Endosc ; 91(1): 142-152.e3, 2020 01.
Article em En | MEDLINE | ID: mdl-31525362
ABSTRACT
BACKGROUND AND

AIMS:

In contrast to the adverse event (AE) risk of endoscopic resection (ER) of adenomas, the intra- and postprocedural AE risks of ER of T1 colorectal cancer (CRC) are scarcely reported in the literature. It is unclear whether ER of early CRCs, which grow into the submucosal layer and sometimes show incomplete lifting, is associated with an increased AE risk. We aimed to identify the AE rate after ER of T1 CRCs and to identify the risk factors associated with these AEs.

METHODS:

Medical records of patients with T1 CRCs diagnosed between 2000 and 2014 in 15 hospitals in the Netherlands were reviewed. Patients who underwent primary ER were selected. The primary outcome was the occurrence of endoscopy-related AEs. The secondary outcome was the identification of risk factors. Multivariate logistic regression was performed.

RESULTS:

Endoscopic AEs occurred in 59 of 1069 (5.5%) patients, among which 37.3% were classified as mild, 59.3% as moderate, and 3.4% as severe. AEs were postprocedural bleeding (n = 40, 3.7%), perforation (n = 13, 1.2%), and postpolypectomy electrocoagulation syndrome (n = 6, 0.6%). No fatal AEs were observed. Independent predictors for AEs were age >70 years (odds ratio, 2.11; 95% confidence interval, 1.12-3.96) and tumor size >20 mm (odds ratio, 2.22; 95% confidence interval, 1.05-4.69).

CONCLUSIONS:

In this large multicenter retrospective cohort study, AE rates of ER of T1 CRC (5.5%) are comparable with reported AE rates for adenomas. Larger tumor size and age >70 years are independent predictors for AEs. This study suggests that endoscopic treatment of T1 CRCs is not associated with an increased periprocedural AE risk.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Carcinoma / Neoplasias Colorretais / Ressecção Endoscópica de Mucosa Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Carcinoma / Neoplasias Colorretais / Ressecção Endoscópica de Mucosa Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda